Cookie Notice

This site uses cookies. By continuing to browse this site, you are agreeing to our use of cookies. Review our cookies information for more details.


Virtual Seminar Forum

International Eosinophil Society 2021 Science Series Webinar
Virtual Seminar:

Barry Kay Memorial – Eosinophils & Airways
April 28
9:30-11:00 AM ET

Previous Seminars
January Virtual Seminar Video - Eosinophils and COVID
February Virtual Seminar Video - Eosinophils and Cancer
March Virtual Seminar Video - Regulatory Eosinophils


Virtual Seminar Abstract Submission

April Seminar Registration

April Virtual Seminar Moderator

Prof. Paul Foster, PhD
Newcastle University
United Kingdom

April Virtual Seminar Speakers

Scientific Breakthroughs in Understanding Asthma and Allergy as uncovered by Barry Kay, Head of Allergy and Clinical Immunology at NHLI, Imperial College London (1980 - 2004)
Prof. Stephen Durham, PhD

Imperial College London
United Kingdom

Prof. Stephen Durham, PhD, is Head of Allergy and Clinical Immunology at National Heart and Lung Institute, Imperial College London and Professor of Allergy and Respiratory Medicine at Royal Brompton Hospital. He trained at Downing College Cambridge and Guy’s Hospital London. After posts in internal medicine in London and Cambridge he undertook research under Professor Barry Kay (1982-4) leading to his Doctorate in Medicine (MD) entitled ‘Immunologic Studies in Late Asthmatic Responses’. Over 40 years Dr Durham’s research has been into basic mechanisms of allergic rhinitis and asthma, local IgE regulation and translational clinical studies of allergen immunotherapy. He has led a general allergy and asthma clinic and a specialist combined medical/surgical rhinology service. He is Past President of the British Society for Allergy and Clinical Immunology. He chaired the Allergy Advisory Group of the Immune Tolerance Network (2012-20). He has an h-index of 145 and over 400 original peer-reviewed publications.



T Cells and Eosinophils in Allergic Asthma: An “On” and “Off” Relationship
Prof. Mark Larché, PhD

McMaster University

Prof. Mark Larché, PhD,completed his PhD in Immunology at the University of London in 1990. He completed postdoctoral fellowships at St. Jude Children’s Research Hospital, Memphis, TN, and St. Mary’s Hospital Medical School (University of London), prior to joining the faculty of the National Heart and Lung Institute, Imperial College London (1995). Since 2006 he has been a Professor of Medicine at McMaster University, Hamilton, Ontario. He currently holds the McMaster University/GSK Chair in Lung Immunology at St. Joseph’s Healthcare. For the past 25+ years his research has focused on the role of T cells in the pathogenesis of asthma and allergic disease, and on manipulating human T cell responses in vivo to achieve immunological tolerance for the treatment of chronic inflammatory diseases. His research encompasses allergic, autoimmune, and transplantation-related disease. He was a scientific co-founder of Circassia Ltd., and Adiga Life Sciences Inc., and he is currently the Deputy Chair of the Michael G. DeGroote initiative for Innovation (MGDII) College of Health Inventors, at McMaster University.


Corporate Advisory Council

Allakos    GSK